Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 22831 - 22840 of 24215
| Identification Number | Trade Name | Benefit Category |
|---|---|---|
| 02548518 | NRA-MONTELUKAST (CHEWABLE TABLET) 4MG | Standard Benefit for Eligible Clients |
| 02548526 | NRA-MONTELUKAST (CHEWABLE TABLET) 5MG | Standard Benefit for Eligible Clients |
| 02548550 | SITAGLIPTIN TAB 25MG | Standard Benefit for Eligible Clients |
| 02548569 | SITAGLIPTIN TAB 50MG | Standard Benefit for Eligible Clients |
| 02548577 | SITAGLIPTIN TAB 100MG | Standard Benefit for Eligible Clients |
| 02548585 | LURASIDONE TAB 20MG | Standard Benefit for Eligible Clients |
| 02548593 | LURASIDONE TAB 40MG | Standard Benefit for Eligible Clients |
| 02548607 | LURASIDONE TAB 60MG | Standard Benefit for Eligible Clients |
| 02548615 | LURASIDONE TAB 80MG | Standard Benefit for Eligible Clients |
| 02548623 | LURASIDONE TAB 120MG | Standard Benefit for Eligible Clients |
Displaying 22831 - 22840 of 24215